Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001390290 | SCV001591971 | pathogenic | Congenital myasthenic syndrome 4A | 2023-05-22 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1076387). This variant is also known as p.Y8X. This premature translational stop signal has been observed in individual(s) with autosomal recessive congenital myasthenic syndrome (PMID: 20157724). This variant is present in population databases (rs748103983, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Tyr28*) in the CHRNE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CHRNE are known to be pathogenic (PMID: 22678886). |
Natera, |
RCV001831403 | SCV002087535 | pathogenic | Congenital myasthenic syndrome | 2020-05-14 | no assertion criteria provided | clinical testing |